0001062993-21-002674.txt : 20210312 0001062993-21-002674.hdr.sgml : 20210312 20210312164054 ACCESSION NUMBER: 0001062993-21-002674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210310 FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Petrova Penka CENTRAL INDEX KEY: 0001838044 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36596 FILM NUMBER: 21738079 MAIL ADDRESS: STREET 1: C/O TRILLIUM THERAPEUTICS INC. STREET 2: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trillium Therapeutics Inc. CENTRAL INDEX KEY: 0001616212 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 BUSINESS PHONE: (416) 595-0627 MAIL ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-03-10 0001616212 Trillium Therapeutics Inc. TRIL 0001838044 Petrova Penka C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 ONTARIO, CANADA 0 1 0 0 Chief Development Officer Common Shares 2021-03-10 4 M 0 2708 0.3012 A 2708 D Common Shares 2021-03-10 4 M 0 2604 3.3524 A 5312 D Common Shares 2021-03-10 4 S 0 5312 11.08 D 0 D Stock Option (Right to Buy) .3012 2021-03-10 4 M 0 2708 0 D 2029-11-07 Common Shares 2708 86668 D Stock Option (Right to Buy) 3.3524 2021-03-10 4 M 0 2604 0 D 2028-11-08 Common Shares 2604 52084 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7925 USD. The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7925 USD. 25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months. /s/ James Parsons, Attorney-in-Fact 2021-03-12